Qing Dong, Ph.D.
President and Chief Scientific Officer
Professional Overview
Qing Dong, Ph.D., is a seasoned pharmaceutical executive with over 15 years of experience in drug discovery and development. As the President and Chief Scientific Officer at XinThera, Inc., he is responsible for driving the company's innovative research efforts and overseeing the strategic direction of its pipeline.
Experience Summary
Current Role
As the President and CSO at XinThera, Inc., Dr. Dong is leading the company's research and development initiatives, focusing on the discovery and advancement of novel therapeutic candidates. He is responsible for building a diverse pipeline, fostering collaborative partnerships, and ensuring the efficient execution of the company's scientific programs.
Under Dr. Dong's leadership, XinThera has made significant progress in developing groundbreaking treatments for complex diseases, with several promising candidates advancing through clinical trials. His strategic vision and scientific expertise have been instrumental in positioning the company as a leading force in the pharmaceutical industry.
Career Progression
Prior to joining XinThera, Dr. Dong served as the President and CSO at Fronthera, where he successfully led the company's research and development efforts, guiding the advancement of multiple drug candidates and forging strategic alliances with industry partners.
Before his role at Fronthera, Dr. Dong held various leadership positions at Hengrui Pharmaceuticals, Inc., including the role of Chief Scientific Officer. In this capacity, he was responsible for the company's overall research and development strategy, overseeing the progression of several innovative drug candidates from early-stage discovery to late-stage clinical trials.
Earlier in his career, Dr. Dong held positions as a Director of Chemistry and a Principal Scientist at Takeda, where he contributed to the development of several marketed products and pipeline assets.
Academic Background
Dr. Qing Dong holds a Ph.D. in Organic Chemistry from the University of California, Berkeley, where he conducted groundbreaking research in the field of synthetic organic chemistry. His academic achievements and research publications have earned him recognition in the scientific community.
Areas of Expertise
- Drug discovery and development
- Medicinal chemistry and structure-based design
- Preclinical and clinical research
- Strategic leadership and team management
- Collaborative partnerships and technology licensing
Professional Impact
Throughout his career, Dr. Dong has made significant contributions to the pharmaceutical industry. His leadership and scientific expertise have been instrumental in the advancement of several drug candidates, with several compounds reaching late-stage clinical trials and regulatory approval.
Dr. Dong's commitment to innovation and his ability to foster collaborative partnerships have been key factors in his success. He has played a pivotal role in shaping the research and development strategies of the companies he has served, driving the discovery and development of novel therapies that have the potential to improve patient outcomes.
Conclusion
With his extensive experience, proven track record of success, and deep scientific expertise, Dr. Qing Dong is well-positioned to continue driving the growth and success of XinThera, Inc. as the company advances its pipeline and expands its impact on the pharmaceutical industry.
